Life Threatening Airway Angioedema Secondary to Captopril

Abstract

Angioedema associated with Angiotensin-Converting Enzyme Inhibitors (ACEI) is an emergency, which can develop in 0.1-1% of the recipients. Severe life-threatening total airway obstruction secondary to angioedema can occur rarely. In this case report, the clinical approach, diagnosis and treatment of ACEI induced angioedema with special focus on the differential diagnosis from hereditary angioedema are discussed.